Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: RUC-4, a novel small molecule Platelet GPIIb/IIIa inhibitor designed for subcutaneous point of first contact STEMI treatment September 9, 2020
Dr. Marco Valgimigli and Dr. C. Michael Gibson Discuss: Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale July 14, 2020
